Abstract
In recent years, the morbidity prevalence rate of asthma among elementary school children in Japan and the
number of hospitalized patients has been declining. In 2017, the number of asthma deaths in children was zero.
Japanese pediatric guidelines for the treatment and management of asthma (JPGL) are considered to have contributed to the success of pediatric asthma treatment in Japan.
This article explains the latest information on bronchial asthma treatment in children, such as the new findings
of pathology, transition of long-term management drugs for children, characteristics of the latest GINA (Global
Initiative for Asthma), drug therapy for long-term management, response to acute exacerbation, allergen-specific
immunotherapy, patient education, partnership with patients and their family, pediatric transitional care, pediatric
asthma and chronic obstructive pulmonary disease (COPD).
